Clinical Trials Browser

Phase 2 × Papillomavirus Infections × Gels × Clear all

NCT02724254 2018-07-20

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Phase 2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections